Neuronetics Raises $30 Million
Neuronetics Inc., a Malvern, Penn.-based developer of therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses, has raised $30 million in Series D funding. New Leaf Venture Partners led the round, and was joined by return backers Investor Growth Capital, Quaker BioVentures, Three Arch Partners, Onset Ventures, Interwest Partners and KBL Healthcare Ventures. The company previously raised $62.5 million.
3 September 2009•3 mins read
